IVPost
Detroit Area Hospital System to Pay $84.5 Million to Settle False Claims Act Allegations Arising From Improper Payments to Referring Physicians
- Details
- Written by DOJ
- Category: Health Care Fraud
Detroit, Michigan - William Beaumont Hospital, a regional hospital system based in the Detroit, Michigan area, will pay $84.5 million to resolve allegations under the False Claims Act of improper relationships with eight referring physicians, resulting in the submission of false claims to the Medicare, Medicaid and TRICARE programs, the Justice Department announced Thursday.
Treating lymphedema
- Details
- Written by Mayo Clinic
- Category: Medical News
If you're at risk of lymphedema - for instance, if you've recently had cancer surgery involving your lymph nodes - your doctor may diagnose lymphedema based on your signs and symptoms.
Diabetes Emergency Relief Coalition Wins Top Association Honor
- Details
- Written by Michelle Kirkwood
- Category: Health News
Orlando, Florida - The Diabetes Emergency Relief Coalition (Coalition), composed of leading diabetes care and research organizations, will receive the American Society of Association Executives (ASAE) 2018 Summit Power of A Award for helping to provide critical diabetes supplies to regions impacted by Hurricanes Harvey, Irma and Maria, the Coalition announced today.
Carol and Mark A. Atkinson, PhD, Receive American Diabetes Association’s Humanitarian Award
- Details
- Written by IVP
- Category: Latest News
Orlando, Florida - Carol and Mark A. Atkinson, PhD, of Insulin for Life USA, are the recipients of the American Diabetes Association’s® (ADA’s) Humanitarian Award. This one-time award honors their outstanding leadership and humanitarian efforts to support the diabetes community for the Diabetes Emergency Relief Coalition in 2017. The Atkinsons were recognized with the award today at the ADA’s 78th Scientific Sessions, June 22-26, 2018, at the Orange County Convention Center in Orlando.
Dual-Hormone, Artificial Pancreas with Insulin and Pramlintide Significantly Improves Glucose Levels, Compared to Insulin-Only Artificial Pancreas
- Details
- Written by Michelle Kirkwood
- Category: Latest News
Orlando, Florida - A dual-hormone, artificial pancreas delivering rapid insulin and the drug pramlintide improved glucose control and reduced glucose variability in adults with type 1 diabetes (T1D) compared to an insulin-only, first-generation artificial pancreas, according to the study, “Insulin-plus-Pramlintide Artificial Pancreas in Type 1 Diabetes—Randomized Controlled Trial,” presented today at the American Diabetes Association’s® (ADA’s) 78th Scientific Sessions® at the Orange County Convention Center Convention Center.
Identifying and Reducing Gender Gaps in Diabetes—Care, Research and the Health Care Profession
- Details
- Written by Michelle Kirkwood
- Category: Medical News
Orlando, Florida - Gender disparities exist in clinical practice and academic medicine when it comes to career opportunities and treatment. According to a November 2017 report from the U.S. Bureau of Labor Statistics (BLS), nearly 47 percent of the U.S. workforce are women. In 2011, the BLS also reported that only 34 percent of physicians and surgeons were women.
Page 1 of 48